Tag: CDMO
Opportunities in Japan’s regenerative medicine, gene therapy markets
Japan emerges as a hub for regenerative medicine, with opportunities for foreign companies amid strict local regulations
Japan emerges as a hub for regenerative medicine, with opportunities for foreign companies amid strict local regulations
Paul Chow shares his views on shaping HKEX legal strategy, sustainability leadership and responsible AI use in markets